Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
about
Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET ImagingSodium channel β subunits: emerging targets in channelopathiesAmyloid and tau cerebrospinal fluid biomarkers in HIV infection.A proteomic approach for the diagnosis of bacterial meningitisNeuroinflammation in Lyme neuroborreliosis affects amyloid metabolismCognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study.Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's diseaseSynaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathwayBACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.The proteomic toolbox for studying cerebrospinal fluid.Molecular biomarkers of neurodegeneration.Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis.Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple Sclerosis.Voltage-Gated Sodium Channel β Subunits and Their Related Diseases.Voltage-gated sodium channel β subunits: The power outside the pore in brain development and disease.Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease.CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease.Cerebrospinal fluid levels of soluble amyloid precursor protein and β-amyloid 42 in patients with multiple sclerosis, neuromyelitis optica and clinically isolated syndrome.Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis.Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.
P2860
Q26750249-17411F01-9519-453B-B603-D31EDD3B4EF7Q28082122-766EB100-3A9C-4315-945B-86F292B64FADQ33520347-C076BA3C-79B8-4A21-AA92-4393B4887BF8Q33553299-AD3EA02F-B68B-49E1-BEDA-CD7F339F837FQ33612995-B43B9293-E716-4EFB-98CC-5B5B22521B0EQ34661859-1DA53E7E-110B-45F5-92E3-E948738CD4A8Q35008855-6F2304A4-A79D-4185-AF5F-8BB040590C05Q35119389-09227B36-E246-48B4-8AE7-78F196A5C219Q37350716-0360E81D-5D56-41EC-B2E2-53BB5ECB0A94Q37652424-73C3370D-9D82-4813-AA06-8B3C91739CB4Q37664735-E2F5DF8D-5776-491C-AF11-D96C19458532Q37998531-0D7C05B8-E936-4FD0-A3C3-2AE23872006DQ38154930-8AB2B3C6-A94D-4BE2-9C62-524219DA4121Q38782456-2B85336A-C693-4AAD-BE4E-E8BDE2382478Q41907099-9BFCDB3E-84F3-48B1-80F3-4DBF45027DC9Q46045880-5F51531C-E95F-44BA-A5DF-B64AB6AB8227Q47117780-A2AFC908-C37C-4FFD-8038-1FED34C14AA0Q47720312-5B2F5119-7CE6-4725-8CBB-F4BD457D6CB1Q47776524-CA9890E9-1244-4862-954C-699B8E043D01Q48400950-8DE59CAA-4769-4049-89A0-0DF45906E84CQ48474028-D1D7B054-3CB6-455E-8185-A5FCBE20861BQ48650878-0F549D6E-B13A-4F72-95CD-87B33582DA3DQ48684415-C9476183-170C-41B3-9A48-7A8F6E147FBCQ49161820-6A3FD6B8-7FBD-40B7-8E83-7340847CFC65Q53333738-9A1AFD12-E0BB-43EC-9AB6-69ECBEE35F20
P2860
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
@en
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
@nl
type
label
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
@en
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
@nl
prefLabel
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
@en
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
@nl
P2093
P2860
P50
P356
P1476
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
@en
P2093
A Gundersen
A Tarkowski
E Trysberg
M Axelsson
O Andersen
P2860
P304
P356
10.1177/1352458508100031
P577
2009-01-19T00:00:00Z